CD69 and neoplasm: While this is a classic marker for early leukocyte activation, CD69 expression can allow the retention of T cells within inflamed tissues to exacerbate inflammation and tumor progression [55,56], and this observation suggests that the T cells present within the tumor were restricted in their effector function.